Exact Mass: 323.1521

Exact Mass Matches: 323.1521

Found 500 metabolites which its exact mass value is equals to given mass value 323.1521, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Bialaphos

γ-(Hydroxymethylphosphinyl)-L-α-aminobutyryl-L-alanyl-L- alanine

C11H22N3O6P (323.1246)


A tripeptide comprising one L-phosphinothricyl and two L-alanyl units joined in sequence. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents D010575 - Pesticides > D006540 - Herbicides D016573 - Agrochemicals

   

FLUTOLANIL

Pesticide4_Flutolanil_C17H16F3NO2_Benzamide, N-[3-(1-methylethoxy)phenyl]-2-(trifluoromethyl)-

C17H16F3NO2 (323.1133)


CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4349; ORIGINAL_PRECURSOR_SCAN_NO 4346 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4226; ORIGINAL_PRECURSOR_SCAN_NO 4222 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9058; ORIGINAL_PRECURSOR_SCAN_NO 9056 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9153; ORIGINAL_PRECURSOR_SCAN_NO 9152 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4243; ORIGINAL_PRECURSOR_SCAN_NO 4241 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4249; ORIGINAL_PRECURSOR_SCAN_NO 4247 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9072; ORIGINAL_PRECURSOR_SCAN_NO 9070 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX508; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9189; ORIGINAL_PRECURSOR_SCAN_NO 9186 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4277; ORIGINAL_PRECURSOR_SCAN_NO 4275 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9107; ORIGINAL_PRECURSOR_SCAN_NO 9105 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX499; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4271; ORIGINAL_PRECURSOR_SCAN_NO 4268 CONFIDENCE standard compound; INTERNAL_ID 1175; DATASET 20200303_ENTACT_RP_MIX503; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9124; ORIGINAL_PRECURSOR_SCAN_NO 9123

   

Paromamine

CHEMBL431061

C12H25N3O7 (323.1692)


   

stylopine

6,7,12b,13e-Tetrahydro-4H-bis[1,3]benzodioxolo[5,6-a:4,5- g]quinolizine

C19H17NO4 (323.1158)


   

Acremoauxin A

Acremoauxin A; 2-(3-Indolyl)propanoylmannitol

C16H21NO6 (323.1369)


An indolyl carboxylate ester obtained by formal condensation of one of the primary hydroxy groups of D-arabinitol with the carboxy group of (2R)-2-(indol-3-yl)propanoic acid.

   

Galipine

3-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methoxyquinoline

C20H21NO3 (323.1521)


   

Rutacridone epoxide

5-hydroxy-11-methyl-2-(2-methyloxiran-2-yl)-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C19H17NO4 (323.1158)


Rutacridone epoxide is an alkaloid from roots and callus tissue cultures of Ruta graveolens (rue). Alkaloid from roots and callus tissue cultures of Ruta graveolens (rue).

   

Alloxydim

methyl 2,2-dimethyl-4,6-dioxo-5-[(E)-N-prop-2-enoxy-C-propylcarbonimidoyl]cyclohexane-1-carboxylate

C17H25NO5 (323.1733)


   

KANAMYCIN A RELATED COMPOUND 1

KANAMYCIN A RELATED COMPOUND 1

C12H25N3O7 (323.1692)


   

L-4-Hydroxyphenylglycyl-L-arginine

L-4-Hydroxyphenylglycyl-L-arginine; L-pHPg-L-Arg

C14H21N5O4 (323.1593)


   

Rucaparib

Rucaparib

C19H18FN3O (323.1434)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   

Pararosaniline Hydrochloride

Pararosaniline Hydrochloride

C19H18ClN3 (323.1189)


D004396 - Coloring Agents > D012394 - Rosaniline Dyes D005404 - Fixatives

   

Naftifine hydrochloride

Naftifine hydrochloride

C21H22ClN (323.1441)


D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Senicapoc

Senicapoc

C20H15F2NO (323.1122)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Histidyltryptophyldiketopiperazine

Histidyltryptophyldiketopiperazine

C17H17N5O2 (323.1382)


   

Cyproheptadine hydrochloride

Cyproheptadine hydrochloride

C21H22ClN (323.1441)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials D003879 - Dermatologic Agents > D000982 - Antipruritics D005765 - Gastrointestinal Agents D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS Cyproheptadine hydrochloride is a potent and orally active 5-HT2A receptor antagonist, with antidepressant and antiserotonergic effects. Cyproheptadine hydrochloride has antiplatelet and thromboprotective activities. Cyproheptadine hydrochloride can be used for the research of thromboembolic disorders[1][2].

   

Methyl N-acetylneuraminate

n-acetylneuraminic acid methyl ester

C12H21NO9 (323.1216)


   

Gliclazide

1-(4-methylbenzenesulfonyl)-3-{octahydrocyclopenta[c]pyrrol-2-yl}urea

C15H21N3O3S (323.1304)


Gliclazide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating β cells of the pancreas to release insulin. Sulfonylureas increase both basal insulin secretion and meal-stimulated insulin release. Medications in this class differ in their dose, rate of absorption, duration of action, route of elimination and binding site on their target pancreatic β cell receptor. Sulfonylureas also increase peripheral glucose utilization, decrease hepatic gluconeogenesis and may increase the number and sensitivity of insulin receptors. Sulfonylureas are associated with weight gain, though less so than insulin. Due to their mechanism of action, sulfonylureas may cause hypoglycemia and require consistent food intake to decrease this risk. The risk of hypoglycemia is increased in elderly, debilitated and malnourished individuals. Gliclazide has been shown to decrease fasting plasma glucose, postprandial blood glucose and glycosolated hemoglobin (HbA1c) levels (reflective of the last 8-10 weeks of glucose control). Gliclazide is extensively metabolized by the liver; its metabolites are excreted in both urine (60-70\\%) and feces (10-20\\%). A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas D007004 - Hypoglycemic Agents

   

(S)-Neolitsine

13-methyl-5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2,4(8),9,16,18(22)-hexaene

C19H17NO4 (323.1158)


(S)-Neolitsine is found in herbs and spices. (S)-Neolitsine is an alkaloid from the leaves of Laurus nobilis (bay laurel).

   

N-Methoxycarbonylanonaine

Methyl 3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene-11-carboxylic acid

C19H17NO4 (323.1158)


N-Methoxycarbonylanonaine is found in alcoholic beverages. N-Methoxycarbonylanonaine is an alkaloid from fresh unripe fruits of Rollinia mucosa (biriba). Alkaloid from fresh unripe fruits of Rollinia mucosa (biriba). N-Methoxycarbonylanonaine is found in cherimoya, alcoholic beverages, and fruits.

   

Mukonicine

13,15-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1,3,7,9,11(16),12,14-heptaene

C20H21NO3 (323.1521)


Mukonicine is found in herbs and spices. Mukonicine is an alkaloid from the leaves of Murraya koenigii (curry leaf tree

   

Gravacridonol

5-hydroxy-2-(3-hydroxyprop-1-en-2-yl)-11-methyl-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C19H17NO4 (323.1158)


Gravacridonol is found in herbs and spices. Gravacridonol is an alkaloid from Ruta graveolens (rue). Alkaloid from Ruta graveolens (rue). Gravacridonol is found in herbs and spices.

   

Koenigicine

13,14-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0²,⁷.0¹¹,¹⁶]heptadeca-1,3,7,9,11,13,15-heptaene

C20H21NO3 (323.1521)


Koenigicine is found in herbs and spices. Koenigicine is an alkaloid from the leaves of Murraya koenigii (curryleaf tree

   

N-Monodemethylolopatadine

2-[(2Z)-2-[3-(methylamino)propylidene]-9-oxatricyclo[9.4.0.0³,⁸]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl]acetic acid

C20H21NO3 (323.1521)


N-Monodemethylolopatadine is a metabolite of olopatadine. Olopatadine hydrochloride is an antihistamine (as well as anticholinergic) and mast cell stabilizer, sold as a prescription eye drop (0.2\\% solution, Pataday, manufactured by Alcon). It is used to treat itching associated with allergic conjunctivitis. Olopatadine hydrochloride 0.1\\% is sold as Patanol (or Opatanol in some countries). A nasal spray formulation is sold as Patanase, which was approved by the FDA on April 15, 2008. (Wikipedia)

   

(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine

3-[(10-hydroxydeca-2,8-dien-4-ynoyl)oxy]-4-(trimethylazaniumyl)butanoate

C17H25NO5 (323.1733)


(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine is an acylcarnitine. More specifically, it is an (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-[(2-Benzyl-3-sulfanylpropanoyl)amino]heptanoic acid

7-[(2-Benzyl-1-hydroxy-3-sulphanylpropylidene)amino]heptanoic acid

C17H25NO3S (323.1555)


   

Bialaphos

2-{[2-({2-amino-1-hydroxy-4-[hydroxy(methyl)phosphoryl]butylidene}amino)-1-hydroxypropylidene]amino}propanoate

C11H22N3O6P (323.1246)


   

Cyamemazine

10-[3-(dimethylamino)-2-methylpropyl]-10H-phenothiazine-2-carbonitrile

C19H21N3S (323.1456)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Cyamemazine is a neuroleptic agent that contains the phenothiazine chromophore. Cyamemazine is often used as an anxiolytic. Cyamemazine is a potent 5-HT3 (Ki of 12 nM), 5-HT2A (Ki = 1.5 nM) and 5-HT2C (Ki of 75 nM) receptors antagonist with antipsychotic activity[1][2].

   

Dehydromonocrotaline

4,5-Dihydroxy-3,4,5-trimethyl-4,5,8,12,13,13a-hexahydro-2H-[1,6]dioxacycloundecino[2,3,4-gh]pyrrolizine-2,6(3H)-dione

C16H21NO6 (323.1369)


   

pyroglutamyl-histidyl-glycine

2-[(1-Hydroxy-2-{[hydroxy(5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl)methylidene]amino}-3-(4H-imidazol-4-yl)propylidene)amino]acetate

C13H17N5O5 (323.123)


   

Renzapride

4-Amino-N-{1-azabicyclo[3.3.1]nonan-4-yl}-5-chloro-2-methoxybenzene-1-carboximidate

C16H22ClN3O2 (323.14)


   

Rubraca

6-fluoro-2-{4-[(methylamino)methyl]phenyl}-3,10-diazatricyclo[6.4.1.0^{4,13}]trideca-1,4,6,8(13)-tetraen-9-one

C19H18FN3O (323.1434)


L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01X - Other antineoplastic agents > L01XK - Poly (adp-ribose) polymerase (parp) inhibitors C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C62554 - Poly (ADP-Ribose) Polymerase Inhibitor D000970 - Antineoplastic Agents > D000067856 - Poly(ADP-ribose) Polymerase Inhibitors D004791 - Enzyme Inhibitors C471 - Enzyme Inhibitor

   

Senicapoc

2,2-bis(4-fluorophenyl)-2-phenylacetamide

C20H15F2NO (323.1122)


COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Tetrahydrocoptisine

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2(10),3,8,15(23),16(20),21-hexaene

C19H17NO4 (323.1158)


(±)-Stylopine (Tetrahydrocoptisine) is an alkaloid compound originally isolated from Corydalis tubers that exhibits anti-inflammatory and anti-parasitic activities[1][2]. (±)-Stylopine (Tetrahydrocoptisine) is an alkaloid compound originally isolated from Corydalis tubers that exhibits anti-inflammatory and anti-parasitic activities[1][2].

   

Tetranor-(+)-S-145

3-{3-benzenesulphonamidobicyclo[2.2.1]heptan-2-yl}propanoic acid

C16H21NO4S (323.1191)


   

Tetrahydrocoptisine

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-2,4(8),9,15(23),16(20),21-hexaene

C19H17NO4 (323.1158)


Stylopine is a natural product found in Fumaria capreolata, Fumaria muralis, and other organisms with data available. (±)-Stylopine (Tetrahydrocoptisine) is an alkaloid compound originally isolated from Corydalis tubers that exhibits anti-inflammatory and anti-parasitic activities[1][2]. (±)-Stylopine (Tetrahydrocoptisine) is an alkaloid compound originally isolated from Corydalis tubers that exhibits anti-inflammatory and anti-parasitic activities[1][2].

   
   
   

Alanyl-2-(1,1-dimethyl-2-propenyl)dehydrotryptophan anhydride

Alanyl-2-(1,1-dimethyl-2-propenyl)dehydrotryptophan anhydride

C19H21N3O2 (323.1634)


   

Carbazoquinocin E

Carbazoquinocin E

C21H25NO2 (323.1885)


   

Furanoclausamine A

(-)-Furanoclausamine A

C19H17NO4 (323.1158)


   

12E-Dechloroisorumbrin

12E-Dechloroisorumbrin

C20H21NO3 (323.1521)


   

Dehydrostesakine

Dehydrostesakine

C19H17NO4 (323.1158)


   
   

5-Hydroxy-9-methylstreptimidone

5-Hydroxy-9-methylstreptimidone

C17H25NO5 (323.1733)


   
   
   
   
   

Cryptoechinuline C

Cryptoechinuline C

C18H17N3O3 (323.127)


   

UNII-88O0DY329T

UNII-88O0DY329T

C20H21NO3 (323.1521)


   
   

CW 69D

3H-Carbazole-3,4(9H)-dione,Carbazoquinocin D

C21H25NO2 (323.1885)


   

Dehydrophanostenine

Dehydrophanostenine

C19H17NO4 (323.1158)


   
   

N-Acetylnornuciferine

N-Acetylnornuciferine

C20H21NO3 (323.1521)


   
   
   

2,3-Dihydromenisporphine

2,3-Dihydromenisporphine

C19H17NO4 (323.1158)


   

Axinisothiocyanate H

Axinisothiocyanate H

C17H25NO3S (323.1555)


   

N-Methyl ovigerine

N-Methyl ovigerine

C19H17NO4 (323.1158)


   

O-Methylglycocitrine-II

O-Methylglycocitrine-II

C20H21NO3 (323.1521)


   

7-Hydroxynoracronycine

7-Hydroxynoracronycine

C19H17NO4 (323.1158)


   

Cyamemazine

Cyamemazine

C19H21N3S (323.1456)


N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics > N05AA - Phenothiazines with aliphatic side-chain C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist Cyamemazine is a neuroleptic agent that contains the phenothiazine chromophore. Cyamemazine is often used as an anxiolytic. Cyamemazine is a potent 5-HT3 (Ki of 12 nM), 5-HT2A (Ki = 1.5 nM) and 5-HT2C (Ki of 75 nM) receptors antagonist with antipsychotic activity[1][2].

   

5HPP-33

2-(2,6-Diisopropylphenyl)-5-hydroxyisoindoline-1,3-dione

C20H21NO3 (323.1521)


CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5214; ORIGINAL_PRECURSOR_SCAN_NO 5211 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5214; ORIGINAL_PRECURSOR_SCAN_NO 5213 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5254; ORIGINAL_PRECURSOR_SCAN_NO 5252 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5226; ORIGINAL_PRECURSOR_SCAN_NO 5223 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5314; ORIGINAL_PRECURSOR_SCAN_NO 5312 ORIGINAL_ACQUISITION_NO 5234; CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 5234; ORIGINAL_PRECURSOR_SCAN_NO 5232 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9749; ORIGINAL_PRECURSOR_SCAN_NO 9744 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9783; ORIGINAL_PRECURSOR_SCAN_NO 9781 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9807; ORIGINAL_PRECURSOR_SCAN_NO 9805 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9830; ORIGINAL_PRECURSOR_SCAN_NO 9826 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9801; ORIGINAL_PRECURSOR_SCAN_NO 9798 CONFIDENCE standard compound; INTERNAL_ID 242; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9831; ORIGINAL_PRECURSOR_SCAN_NO 9828

   

Dimefline HCL

Dimefline HCL

C20H21NO3 (323.1521)


R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants C78272 - Agent Affecting Nervous System > C47795 - CNS Stimulant

   
   
   

2-[6-(diethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

2-[6-(diethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol

C14H21N5O4 (323.1593)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.710 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.712 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.707 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.708

   

TEB_M324a

TEB_M324a

C16H22ClN3O2 (323.14)


CONFIDENCE Transformation product, tentative ID (Level 2b); INTERNAL_ID 2501

   

TEB_M324b *

TEB_M324b *

C16H22ClN3O2 (323.14)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2504

   

TEB_M324c

TEB_M324c

C16H22ClN3O2 (323.14)


CONFIDENCE Transformation product, tentative ID (Level 3 structure); INTERNAL_ID 2505

   

Dehydrodiscretamine

Dehydrodiscretamine

C19H17NO4 (323.1158)


   

ZINC367610589

ZINC367610589

C19H17NO4 (323.1158)


   

12xi-hydroxy-14xi-methyl-(13xiH,15xiH)-15,20-dihydro-18,21-dinor-senecionane-11,16-dione|Crotananin|crotananine

12xi-hydroxy-14xi-methyl-(13xiH,15xiH)-15,20-dihydro-18,21-dinor-senecionane-11,16-dione|Crotananin|crotananine

C17H25NO5 (323.1733)


   

(-)-Neoechinulin A; Neoechinuline A

(-)-Neoechinulin A; Neoechinuline A

C19H21N3O2 (323.1634)


   

(+-)-Teframidine

(+-)-Teframidine

C19H17NO4 (323.1158)


   

N-acetylanolobine

N-acetylanolobine

C19H17NO4 (323.1158)


   
   

acetyl dicrotaline

acetyl dicrotaline

C16H21NO6 (323.1369)


   
   

N-Formylxylopine

N-Formylxylopine

C19H17NO4 (323.1158)


   

Di-N-de-Me-(S)-Thalphenine

Di-N-de-Me-(S)-Thalphenine

C19H17NO4 (323.1158)


   

Methoxy,Ac-2-(4-Hydroxyphenyl)-1-methyl-4(1H)-quinolinone6-

Methoxy,Ac-2-(4-Hydroxyphenyl)-1-methyl-4(1H)-quinolinone6-

C19H17NO4 (323.1158)


   

N-Formylputerine

N-Formylputerine

C19H17NO4 (323.1158)


   
   

Oprea1_325596

Oprea1_325596

C20H21NO3 (323.1521)


   

Macrophylline

Macrophylline

C17H25NO5 (323.1733)


   

(+-)-1,2,10,11-Bismethylendioxyaporphin|(+-)-N-methyl-hernovine|(+-)-N-methyl-ovigerine|7-methyl-6,7,7a,8-tetrahydro-5H-[1,3]dioxolo[4,5:4,5]benzo[1,2,3-de][1,3]dioxolo[4,5:5,6]benzo[1,2-g]quinoline|N-Methyl-ovigerin|N-Methylovigerin

(+-)-1,2,10,11-Bismethylendioxyaporphin|(+-)-N-methyl-hernovine|(+-)-N-methyl-ovigerine|7-methyl-6,7,7a,8-tetrahydro-5H-[1,3]dioxolo[4,5:4,5]benzo[1,2,3-de][1,3]dioxolo[4,5:5,6]benzo[1,2-g]quinoline|N-Methyl-ovigerin|N-Methylovigerin

C19H17NO4 (323.1158)


   

2-(3-methoxycarbonyl-propyl) gardenamide A|genipamide

2-(3-methoxycarbonyl-propyl) gardenamide A|genipamide

C16H21NO6 (323.1369)


   
   

5-hydroxynoracronycine

5-hydroxynoracronycine

C19H17NO4 (323.1158)


A natural product found in Citropsis articulata.

   
   

KQHBFHIQPPASRA-UHFFFAOYSA-

KQHBFHIQPPASRA-UHFFFAOYSA-

C18H17N3O3 (323.127)


   

7-hydroxynoracronycine|9-hydroxynoracronycine

7-hydroxynoracronycine|9-hydroxynoracronycine

C19H17NO4 (323.1158)


   

6-hydroxynoracronycine|citropsine A

6-hydroxynoracronycine|citropsine A

C19H17NO4 (323.1158)


   

3-(4-methoxy-3-methyl-2-oxo-2H-pyran-6-yl)butyl pyroglutamate

3-(4-methoxy-3-methyl-2-oxo-2H-pyran-6-yl)butyl pyroglutamate

C16H21NO6 (323.1369)


   

(-)-monophyllidin

(-)-monophyllidin

C16H21NO6 (323.1369)


   

(+)-(S)-N-propionylcaaverine

(+)-(S)-N-propionylcaaverine

C20H21NO3 (323.1521)


   

8-(4-O-methyl-alpha-rhamnopyranosyloxy)-3,4-dihydroquinolin-2(1H)-one

8-(4-O-methyl-alpha-rhamnopyranosyloxy)-3,4-dihydroquinolin-2(1H)-one

C16H21NO6 (323.1369)


   
   

clausenawalline J

clausenawalline J

C19H17NO4 (323.1158)


   

dihydroneochinulin B

dihydroneochinulin B

C19H21N3O2 (323.1634)


   
   

2,10-dimethoxy-7-hydroxy-aporphine

2,10-dimethoxy-7-hydroxy-aporphine

C19H17NO4 (323.1158)


   

tuberostemoline B

tuberostemoline B

C17H25NO5 (323.1733)


   
   

3-O-methylglycocitrine-II|O3-Me-Glycocitrine II

3-O-methylglycocitrine-II|O3-Me-Glycocitrine II

C20H21NO3 (323.1521)


   
   

Carbazoquinocin D

Carbazoquinocin D

C21H25NO2 (323.1885)


   

1-Hydoxy-3-methoxy-2-(3-methyl-2-butenyl)-10-methylacridone|1-hydroxy-3-methoxy-2-(3-methylbut-2-enyl)-N-methylacridan-9-one

1-Hydoxy-3-methoxy-2-(3-methyl-2-butenyl)-10-methylacridone|1-hydroxy-3-methoxy-2-(3-methylbut-2-enyl)-N-methylacridan-9-one

C20H21NO3 (323.1521)


   

Furofoline II|furofoline-II

Furofoline II|furofoline-II

C19H17NO4 (323.1158)


   

N-Acetyl-8alpha-hydroxyparthenolidine

N-Acetyl-8alpha-hydroxyparthenolidine

C17H25NO5 (323.1733)


   

isonaamine B|naamine A

isonaamine B|naamine A

C19H21N3O2 (323.1634)


   

ANOREXIGENICPEPTIDE

ANOREXIGENICPEPTIDE

C13H17N5O5 (323.123)


   

2-amino-9-[6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-3H-purin-6-one

2-amino-9-[6-(hydroxymethyl)-2,2-dimethyl-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-4-yl]-3H-purin-6-one

C13H17N5O5 (323.123)


   

(+/-)-N-Methylguattescidine

(+/-)-N-Methylguattescidine

C19H17NO4 (323.1158)


   
   

Diphenylmethyl ester-Clavam-2-carboxylate

Diphenylmethyl ester-Clavam-2-carboxylate

C19H17NO4 (323.1158)


   

CHEMBL3946997

CHEMBL3946997

C19H17NO4 (323.1158)


   

(+)-Crystamidine

(+)-Crystamidine

C19H17NO4 (323.1158)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)Propanoic acid

(S)-2-((S)-3-(1H-Imidazol-4-yl)-2-((S)-pyrrolidine-2-carboxamido)Propanamido)Propanoic acid

C14H21N5O4 (323.1593)


   

MS-PPOH

N-(methylsulfonyl)-2-(2-propynyloxy)-benzenehexanamide

C16H21NO4S (323.1191)


   

piperidolate

piperidolate

C21H25NO2 (323.1885)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03A - Drugs for functional gastrointestinal disorders > A03AA - Synthetic anticholinergics, esters with tertiary amino group C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent Piperidolate is an antimuscarinic, inhibits intestinal cramp induced by acetylcholine (rats and dogs).

   
   

SCHEMBL10716722

SCHEMBL10716722

C15H21N3O5 (323.1481)


   

Dehydrocoreximine

Dehydrocoreximine

C19H17NO4 (323.1158)


   

dehydroscoulerine

dehydroscoulerine

C19H17NO4 (323.1158)


   

n-acetylneuraminic acid methyl ester

N-Acetylneuraminic acid methyl ester 1

C12H21NO9 (323.1216)


relative retention time with respect to 9-anthracene Carboxylic Acid is 0.053 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.052 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.054

   

Ritodrine hydrochloride

Ritodrine hydrochloride (Yutopar)

C17H22ClNO3 (323.1288)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents Ritodrine (DU21220) hydrochloride is a potent and orally active β-adrenergic agonist. Ritodrine hydrochloride decreases preterm delivery and uterine contraction. Ritodrine hydrochloride has the potential for the research of preterm labor[1][2].

   

Naftifine HCl

Naftifine HCl

C21H22ClN (323.1441)


   

neoechinulin A

cyclo-L-2-tert-DMA-Trp-L-Ala Delta(10,11)

C19H21N3O2 (323.1634)


   

(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione

NCGC00347564-02!(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione

C19H21N3O2 (323.1634)


   

Tobramycin rings B and C

Tobramycin rings B and C

C12H25N3O7 (323.1692)


   

C17H25NO5

NCGC00381005-01_C17H25NO5_

C17H25NO5 (323.1733)


   

C17H17N5O2_3-(1H-Imidazol-4-ylmethyl)-6-(1H-indol-3-ylmethyl)-2,5-piperazinedione

NCGC00385408-01_C17H17N5O2_3-(1H-Imidazol-4-ylmethyl)-6-(1H-indol-3-ylmethyl)-2,5-piperazinedione

C17H17N5O2 (323.1382)


   

Tobramycin, fragment AB or degraded

Tobramycin, fragment AB or degraded

C12H25N3O7 (323.1692)


   

gliclazide

gliclazide

C15H21N3O3S (323.1304)


A - Alimentary tract and metabolism > A10 - Drugs used in diabetes > A10B - Blood glucose lowering drugs, excl. insulins > A10BB - Sulfonylureas D007004 - Hypoglycemic Agents

   

(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione [IIN-based: Match]

NCGC00347564-02!(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione [IIN-based: Match]

C19H21N3O2 (323.1634)


   

(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione [IIN-based on: CCMSLIB00000845126]

NCGC00347564-02!(3S,6Z)-3-methyl-6-[[2-(2-methylbut-3-en-2-yl)-1H-indol-3-yl]methylidene]piperazine-2,5-dione [IIN-based on: CCMSLIB00000845126]

C19H21N3O2 (323.1634)


   

CP-457920

CP-457920

C18H17N3O3 (323.127)


CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4233; ORIGINAL_PRECURSOR_SCAN_NO 4230 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4258; ORIGINAL_PRECURSOR_SCAN_NO 4256 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4255; ORIGINAL_PRECURSOR_SCAN_NO 4253 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4244; ORIGINAL_PRECURSOR_SCAN_NO 4242 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 4263; ORIGINAL_PRECURSOR_SCAN_NO 4259 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8818; ORIGINAL_PRECURSOR_SCAN_NO 8816 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8814; ORIGINAL_PRECURSOR_SCAN_NO 8811 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8832; ORIGINAL_PRECURSOR_SCAN_NO 8830 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8850; ORIGINAL_PRECURSOR_SCAN_NO 8845 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8851; ORIGINAL_PRECURSOR_SCAN_NO 8850 CONFIDENCE standard compound; INTERNAL_ID 1280; DATASET 20200303_ENTACT_RP_MIX504; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 8856; ORIGINAL_PRECURSOR_SCAN_NO 8854

   

1,N2-6-Hydroxypropano-deoxyguanosine

1,N2-6-Hydroxypropano-deoxyguanosine

C13H17N5O5 (323.123)


   

1,N2-8-Hydroxypropano-deoxyguanosine

1,N2-8-Hydroxypropano-deoxyguanosine

C13H17N5O5 (323.123)


   
   
   
   
   
   
   
   

Morphinan-3-ol, hydrogen sulfate

Morphinan-3-ol, hydrogen sulfate

C16H21NO4S (323.1191)


   
   
   
   
   
   
   
   

3-Pyrrolidineacetic acid, 1-ethyl-5-oxo-4,4-diphenyl- (9CI)

3-Pyrrolidineacetic acid, 1-ethyl-5-oxo-4,4-diphenyl- (9CI)

C20H21NO3 (323.1521)


   

Zolpidem Metabolite X-1

Zolpidem Metabolite X-1

C19H21N3O2 (323.1634)


   

Zolpidem Metabolite X-2

Zolpidem Metabolite X-2

C19H21N3O2 (323.1634)


   

CAY10449

4,5-dihydro-N-[4-[[4-(1-methylethoxy)phenyl]carbonyl]phenyl]-1H-imadazol-2-amine

C19H21N3O2 (323.1634)


   

N-Acetyl-8-O-methyl-Neuraminic acid

N-Acetyl-8-O-methyl-Neuraminic acid

C12H21NO9 (323.1216)


   

2H-1-Benzopyran-2-one, 3-[1-(4-aminophenyl)-3-oxobutyl]-4-hydroxy-, (S)- (Acenocoumarol metabolite)

2H-1-Benzopyran-2-one, 3-[1-(4-aminophenyl)-3-oxobutyl]-4-hydroxy-, (S)- (Acenocoumarol metabolite)

C19H17NO4 (323.1158)


   

Kenidine

13,14-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaene

C20H21NO3 (323.1521)


   

Mukonicine

13,15-dimethoxy-5,5,8-trimethyl-6-oxa-17-azatetracyclo[8.7.0.0^{2,7}.0^{11,16}]heptadeca-1,3,7,9,11,13,15-heptaene

C20H21NO3 (323.1521)


   

Neolitsine

13-methyl-5,7,19,21-tetraoxa-13-azahexacyclo[10.10.1.0^{2,10}.0^{4,8}.0^{16,23}.0^{18,22}]tricosa-1(23),2,4(8),9,16,18(22)-hexaene

C19H17NO4 (323.1158)


   

Gravacridonol

5-hydroxy-2-(3-hydroxyprop-1-en-2-yl)-11-methyl-1H,2H,6H,11H-furo[2,3-c]acridin-6-one

C19H17NO4 (323.1158)


   

Romucosine

methyl 3,5-dioxa-11-azapentacyclo[10.7.1.0^{2,6}.0^{8,20}.0^{14,19}]icosa-1(20),2(6),7,14(19),15,17-hexaene-11-carboxylate

C19H17NO4 (323.1158)


   

2-[(4-phenylpiperazin-1-yl)methyl]-1-benzothiophen-5-amine

2-[(4-phenylpiperazin-1-yl)methyl]-1-benzothiophen-5-amine

C19H21N3S (323.1456)


   

1-CBZ-2-BENZYLPIPERIDIN-4-ONE

1-CBZ-2-BENZYLPIPERIDIN-4-ONE

C20H21NO3 (323.1521)


   

Z-Gly-Gly-Gly-OH

Z-Gly-Gly-Gly-OH

C14H17N3O6 (323.1117)


   

1-(Isopropyl(dimethyl)-lambda~5~-azanyl)-3-(1-naphthyloxy)-2-propanol

1-(Isopropyl(dimethyl)-lambda~5~-azanyl)-3-(1-naphthyloxy)-2-propanol

C18H26ClNO2 (323.1652)


   

Metiapine

Metiapine

C19H21N3S (323.1456)


C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent

   

2-(2-Piperidin-1-ylethoxy)benzaldehyde

2-(2-Piperidin-1-ylethoxy)benzaldehyde

C16H21NO6 (323.1369)


   

tert-butyl 4-(5-nitropyridin-2-yl)oxypiperidine-1-carboxylate

tert-butyl 4-(5-nitropyridin-2-yl)oxypiperidine-1-carboxylate

C15H21N3O5 (323.1481)


   

1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID

1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-4-CARBOXYLIC ACID

C17H22FNO4 (323.1533)


   

Anorexigenic Peptide

Anorexigenic Peptide

C13H17N5O5 (323.123)


   

METHYL 2-METHYL-8-OXO-3-PHENYL-5,6,7,8-TETRAHYDRO-1-OXA-7A-AZAINDACENE-4-CARBOXYLATE

METHYL 2-METHYL-8-OXO-3-PHENYL-5,6,7,8-TETRAHYDRO-1-OXA-7A-AZAINDACENE-4-CARBOXYLATE

C19H17NO4 (323.1158)


   

tert-butyl 4-(3-nitropyridin-2-yl)oxypiperidine-1-carboxylate

tert-butyl 4-(3-nitropyridin-2-yl)oxypiperidine-1-carboxylate

C15H21N3O5 (323.1481)


   

Mepixanox

Mepixanox

C20H21NO3 (323.1521)


R - Respiratory system > R07 - Other respiratory system products > R07A - Other respiratory system products > R07AB - Respiratory stimulants C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent

   

Boc-β-HomoThr(Bzl)-OH

Boc-β-HomoThr(Bzl)-OH

C17H25NO5 (323.1733)


   

(1r,2r)-2-(naphthalene-2,3-dicarboximido)cyclohexanecarboxylic acid

(1r,2r)-2-(naphthalene-2,3-dicarboximido)cyclohexanecarboxylic acid

C19H17NO4 (323.1158)


   

4-(TERT-BUTOXYCARBONYL(4-METHOXYBENZYL)AMINO)BUTANOIC ACID

4-(TERT-BUTOXYCARBONYL(4-METHOXYBENZYL)AMINO)BUTANOIC ACID

C17H25NO5 (323.1733)


   

BOC--(4-FLUORBENZYL)-DL-PRO-OH

BOC--(4-FLUORBENZYL)-DL-PRO-OH

C17H22FNO4 (323.1533)


   

(4-ISOPROPYLPHENYL)(2-NITRO-5-(PROP-2-YNYLOXY)PHENYL)METHANONE

(4-ISOPROPYLPHENYL)(2-NITRO-5-(PROP-2-YNYLOXY)PHENYL)METHANONE

C19H17NO4 (323.1158)


   

2-N-BOC-3-(4-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

2-N-BOC-3-(4-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

C17H25NO5 (323.1733)


   

2-N-BOC-3-(3-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

2-N-BOC-3-(3-METHOXY-PHENYL)-2-METHYLAMINOMETHYL-PROPIONIC ACID

C17H25NO5 (323.1733)


   

MNI-caged-L-glutamate

MNI-caged-L-glutamate

C14H17N3O6 (323.1117)


   

Boc-L-aspartic acid 4-benzyl ester

Boc-L-aspartic acid 4-benzyl ester

C16H21NO6 (323.1369)


   

boc-(r)-alpha-(4-fluorobenzyl)-proline

boc-(r)-alpha-(4-fluorobenzyl)-proline

C17H22FNO4 (323.1533)


   

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-fluorobenzyl)pyrrolidine-2-carboxylic acid

(2S,4R)-1-(tert-Butoxycarbonyl)-4-(2-fluorobenzyl)pyrrolidine-2-carboxylic acid

C17H22FNO4 (323.1533)


   

METHYL 2-N-BOC-2-AMINOMETHYL-3-(3-METHOXY-PHENYL)-PROPIONATE

METHYL 2-N-BOC-2-AMINOMETHYL-3-(3-METHOXY-PHENYL)-PROPIONATE

C17H25NO5 (323.1733)


   

(R)-N-Fmoc-Azetidine-2-Carboxylic Acid

(R)-N-Fmoc-Azetidine-2-Carboxylic Acid

C19H17NO4 (323.1158)


   

2-O-METHYL-ALPHA-D-N-ACETYLNEURAMINIC ACID

2-O-METHYL-ALPHA-D-N-ACETYLNEURAMINIC ACID

C12H21NO9 (323.1216)


   

1-BOC-4-(4-CHLOROBENZOYL)PIPERIDINE

1-BOC-4-(4-CHLOROBENZOYL)PIPERIDINE

C17H22ClNO3 (323.1288)


   

Renzapride

Renzapride

C16H22ClN3O2 (323.14)


Renzapride (BRL 24924), a substituted benzamide, is a full 5-HT4 receptor agonist with a Ki value of 115 nM. Renzapride (BRL 24924) is also a 5HT2b and 5HT3 receptor antagonist[1]. Renzapride could be used for constipation predominant irritable bowel syndrome (C-IBS) study[2].

   

(2S)-1-(9H-fluoren-9-ylmethoxycarbonyl)azetidine-2-carboxylic acid

(2S)-1-(9H-fluoren-9-ylmethoxycarbonyl)azetidine-2-carboxylic acid

C19H17NO4 (323.1158)


   

(S)-5-GUANIDINO-2-(4-NITROBENZAMIDO)PENTANOIC ACID

(S)-5-GUANIDINO-2-(4-NITROBENZAMIDO)PENTANOIC ACID

C13H17N5O5 (323.123)


   

Fmoc-azetidine-3-carboxylic acid

Fmoc-azetidine-3-carboxylic acid

C19H17NO4 (323.1158)


   

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide

N-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)benzamide

C19H22BNO3 (323.1693)


   

N5-(1-CYCLOHEPTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-YL)PYRIDINE-2,5-DIAMINE

N5-(1-CYCLOHEPTYL-1H-PYRAZOLO[3,4-D]PYRIMIDIN-6-YL)PYRIDINE-2,5-DIAMINE

C17H21N7 (323.1858)


   

ethyl 5,5,5-trifluoro-4-naphthalen-1-yliminopentanoate

ethyl 5,5,5-trifluoro-4-naphthalen-1-yliminopentanoate

C17H16F3NO2 (323.1133)


   

(2S)-2-phenyl-2-[[(1S)-1-[4-(trifluoromethyl)phenyl]propyl]amino]ethanol

(2S)-2-phenyl-2-[[(1S)-1-[4-(trifluoromethyl)phenyl]propyl]amino]ethanol

C18H20F3NO (323.1497)


   

N-(2,5-Dimethoxyphenyl)-3-hydroxy-2-naphthamide

N-(2,5-Dimethoxyphenyl)-3-hydroxy-2-naphthamide

C19H17NO4 (323.1158)


   

boc-(s)-alpha-(4-fluorobenzyl)-proline

boc-(s)-alpha-(4-fluorobenzyl)-proline

C17H22FNO4 (323.1533)


   
   

N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide

N-cyclopropyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide

C15H22BNO4S (323.1363)


   

H-Ala-Tyr-Ala-OH

(2S)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]propanoic Acid

C15H21N3O5 (323.1481)


   

N-(3-HYDROXY-4,7,7-TRIMETHYL-BICYCLO[2.2.1]HEPT-2-YL)-4-METHYL-BENZENESULFONAMIDE

N-(3-HYDROXY-4,7,7-TRIMETHYL-BICYCLO[2.2.1]HEPT-2-YL)-4-METHYL-BENZENESULFONAMIDE

C17H25NO3S (323.1555)


   

(±)-Octanoylcarnitine chloride

(±)-Octanoylcarnitine chloride

C15H30ClNO4 (323.1863)


   
   

Fmoc-1-aminocyclopropane-1-carboxylic acid

Fmoc-1-aminocyclopropane-1-carboxylic acid

C19H17NO4 (323.1158)


   

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID

(3S,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID

C17H22FNO4 (323.1533)


   

(3R,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID

(3R,4R)-1-(TERT-BUTOXYCARBONYL)-4-(4-FLUOROPHENYL)PIPERIDINE-3-CARBOXYLIC ACID

C17H22FNO4 (323.1533)


   

Fmoc-Prolinol

Fmoc-Prolinol

C20H21NO3 (323.1521)


   

METHYL (2S,5R)-1-CBZ-5-HYDROXY-6-METHOXYPIPECOLINATE

METHYL (2S,5R)-1-CBZ-5-HYDROXY-6-METHOXYPIPECOLINATE

C16H21NO6 (323.1369)


   

N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-4-pyrazolyl)butane-1-sulfonamide

N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-4-pyrazolyl)butane-1-sulfonamide

C15H21N3O3S (323.1304)


   

(4-(4-Aminoquinazolin-2-yl)piperazin-1-yl)(furan-2-yl)methanone

(4-(4-Aminoquinazolin-2-yl)piperazin-1-yl)(furan-2-yl)methanone

C17H17N5O2 (323.1382)


   

TERT-BUTYL 6-(BENZYLOXY)-1H-INDOLE-1-CARBOXYLATE

TERT-BUTYL 6-(BENZYLOXY)-1H-INDOLE-1-CARBOXYLATE

C20H21NO3 (323.1521)


   

N-FMOC-4-PIPERIDINOL

N-FMOC-4-PIPERIDINOL

C20H21NO3 (323.1521)


   

2-fluoro-4-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]benzoic acid

2-fluoro-4-[1-[(2-methylpropan-2-yl)oxycarbonyl]piperidin-4-yl]benzoic acid

C17H22FNO4 (323.1533)


   

2-[3-(2H-Benzotriazol-2-yl)-4-hydroxyphenyl]ethyl methacrylate

2-[3-(2H-Benzotriazol-2-yl)-4-hydroxyphenyl]ethyl methacrylate

C18H17N3O3 (323.127)


   

Alcaftadine 3-Carboxylic Acid

Alcaftadine 3-Carboxylic Acid

C19H21N3O2 (323.1634)


   

TRANS-METHYL 1-(METHYLSULFONYL)SPIRO[CYCLOHEXANE-1,3-INDOLINE]-4-CARBOXYLATE

TRANS-METHYL 1-(METHYLSULFONYL)SPIRO[CYCLOHEXANE-1,3-INDOLINE]-4-CARBOXYLATE

C16H21NO4S (323.1191)


   

5-(PIPERIDINE-1-SULFONYL)-2-PIPERIDIN-1-YL-PHENYLAMINE

5-(PIPERIDINE-1-SULFONYL)-2-PIPERIDIN-1-YL-PHENYLAMINE

C16H25N3O2S (323.1667)


   

alloxydim-sodium

alloxydim-sodium

C17H25NO5 (323.1733)


   

(9H-FLUOREN-9-YL)METHYL 3-HYDROXYPIPERIDINE-1-CARBOXYLATE

(9H-FLUOREN-9-YL)METHYL 3-HYDROXYPIPERIDINE-1-CARBOXYLATE

C20H21NO3 (323.1521)


   

2,3-O-Isopropylideneguanosine

2,3-O-Isopropylideneguanosine

C13H17N5O5 (323.123)


   

3-[2-(1-PIPERIDINYL)ETHOXY]BENZALDEHYDE OXALATE

3-[2-(1-PIPERIDINYL)ETHOXY]BENZALDEHYDE OXALATE

C16H21NO6 (323.1369)


   

Boc-D-Asp-OBzl

Boc-D-Asp-OBzl

C16H21NO6 (323.1369)


   

(1s,2s)-2-(naphthalene-2,3-dicarboximido)cyclohexanecarboxylic acid

(1s,2s)-2-(naphthalene-2,3-dicarboximido)cyclohexanecarboxylic acid

C19H17NO4 (323.1158)


   

Boc-N-methyl-O-benzyl-L-threonine

Boc-N-methyl-O-benzyl-L-threonine

C17H25NO5 (323.1733)


   

(R)-tert-butyl 3-(3-chlorobenzoyl)piperidine-1-carboxylate

(R)-tert-butyl 3-(3-chlorobenzoyl)piperidine-1-carboxylate

C17H22ClNO3 (323.1288)


   

Disperse Orange 25

Disperse Orange 25

C17H17N5O2 (323.1382)


   

4-(Phenylaminocarbonyl)benzeneboronic acid pinacol ester

4-(Phenylaminocarbonyl)benzeneboronic acid pinacol ester

C19H22BNO3 (323.1693)


   

[4-(6-aminopurin-9-yl)-2-ethoxy-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methanol

[4-(6-aminopurin-9-yl)-2-ethoxy-3a,4,6,6a-tetrahydrofuro[3,4-d][1,3]dioxol-6-yl]methanol

C13H17N5O5 (323.123)


   

N-Desmethyl Olopatadine

N-Desmethyl Olopatadine

C20H21NO3 (323.1521)


   

Cinnamaverine

Cinnamaverine

C21H25NO2 (323.1885)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent

   

3-hydroxy-N-(1-methylpyrazol-3-yl)-5-phenylmethoxybenzamide

3-hydroxy-N-(1-methylpyrazol-3-yl)-5-phenylmethoxybenzamide

C18H17N3O3 (323.127)


   

methyl 1-[(4-methoxyphenyl)methyl]-4-oxoquinoline-3-carboxylate

methyl 1-[(4-methoxyphenyl)methyl]-4-oxoquinoline-3-carboxylate

C19H17NO4 (323.1158)


   

9H-fluoren-9-ylmethyl (3R)-3-hydroxypiperidine-1-carboxylate

9H-fluoren-9-ylmethyl (3R)-3-hydroxypiperidine-1-carboxylate

C20H21NO3 (323.1521)


   

9H-fluoren-9-ylmethyl (3S)-3-hydroxypiperidine-1-carboxylate

9H-fluoren-9-ylmethyl (3S)-3-hydroxypiperidine-1-carboxylate

C20H21NO3 (323.1521)


   

Z-Asp(OtBu)-OH.H2O

Z-Asp(OtBu)-OH.H2O

C16H21NO6 (323.1369)


   
   

(2-hydroxypropyl)ammonium phosphate

(2-hydroxypropyl)ammonium phosphate

C9H30N3O7P (323.1821)


   

Methyl (1R,2R)-2-[(4-amino-4-biphenylyl)carbonyl]cyclopentanecar boxylate

Methyl (1R,2R)-2-[(4-amino-4-biphenylyl)carbonyl]cyclopentanecar boxylate

C20H21NO3 (323.1521)


   

Olopatadine Methanol

Olopatadine Methanol

C21H25NO2 (323.1885)


   

2-[3-(3-hydroxyphenyl)-2,3-dimethylpiperidin-1-yl]-1-phenylethanone

2-[3-(3-hydroxyphenyl)-2,3-dimethylpiperidin-1-yl]-1-phenylethanone

C21H25NO2 (323.1885)


   

5-(tetrahydro-2H-pyran-4-yloxy)pyridine-3-boronic acid pinacol ester

5-(tetrahydro-2H-pyran-4-yloxy)pyridine-3-boronic acid pinacol ester

C16H26BNO5 (323.1904)


   

5-AMINOMETHYL-2-(N,N-DITERT-BUTOXYCARBONYLAMINO)PYRIDINE

5-AMINOMETHYL-2-(N,N-DITERT-BUTOXYCARBONYLAMINO)PYRIDINE

C16H25N3O4 (323.1845)


   

(S)-tert-Butyl 2-(benzyloxycarbonylamino)-5-hydroxypentanoate

(S)-tert-Butyl 2-(benzyloxycarbonylamino)-5-hydroxypentanoate

C17H25NO5 (323.1733)


   

Mycophenolic acid D3

Mycophenolic acid D3

C17H17D3O6 (323.1448)


   

BOC-GLU-PHENYL ESTER

BOC-GLU-PHENYL ESTER

C16H21NO6 (323.1369)


   

Boc-D-Aspartic acid 4-benzyl ester

Boc-D-Aspartic acid 4-benzyl ester

C16H21NO6 (323.1369)


   

3-(4-(Trifluoromethyl)phenoxy)-N,N-dimethyl-3-phenylpropan-1-amine

3-(4-(Trifluoromethyl)phenoxy)-N,N-dimethyl-3-phenylpropan-1-amine

C18H20F3NO (323.1497)


   

4-(1,1-Dioxido-2-isothiazolidinyl)phenylboronic Acid Pinacol Ester

4-(1,1-Dioxido-2-isothiazolidinyl)phenylboronic Acid Pinacol Ester

C15H22BNO4S (323.1363)


   

11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine

11-(4-Ethylpiperazin-1-yl)dibenzo[b,f][1,4]thiazepine

C19H21N3S (323.1456)


   

N,N-bis(trimethylsilyl)aminopropyltrimethoxysilane

N,N-bis(trimethylsilyl)aminopropyltrimethoxysilane

C12H33NO3Si3 (323.1768)


   
   

POLY((ISOBUTYLENE-ALT-MALEIC ACID AMMO&

POLY((ISOBUTYLENE-ALT-MALEIC ACID AMMO&

C19H17NO4 (323.1158)


   

1-Hexyl-4-methylpyridinium hexafluorophosphate

1-Hexyl-4-methylpyridinium hexafluorophosphate

C12H20F6NP (323.1237)


   

2-chloro-N-cyclopentyl-5-(3,3-diethoxy-1-propyn-1-yl)-4-Pyrimidinamine

2-chloro-N-cyclopentyl-5-(3,3-diethoxy-1-propyn-1-yl)-4-Pyrimidinamine

C16H22ClN3O2 (323.14)


   

1-Benzoyl-4-benzylpiperidine-4-carboxylic acid

1-Benzoyl-4-benzylpiperidine-4-carboxylic acid

C20H21NO3 (323.1521)


   

1-phenethyl-3,4-diphenyl-1H-pyrrole

1-phenethyl-3,4-diphenyl-1H-pyrrole

C24H21N (323.1674)


   

4-hydroxy-1-methyl-7-phenoxy-3-Isoquinolinecarboxylic acid ethyl ester

4-hydroxy-1-methyl-7-phenoxy-3-Isoquinolinecarboxylic acid ethyl ester

C19H17NO4 (323.1158)


   

1-Hexyl-3-methylpyridinium hexafluorophosphat

1-Hexyl-3-methylpyridinium hexafluorophosphat

C12H20N.PF6 (323.1237)


   

3-Amino-3-iminopropanoic acid 1-(diphenylmethyl)-3-azetidinyl ester

3-Amino-3-iminopropanoic acid 1-(diphenylmethyl)-3-azetidinyl ester

C19H21N3O2 (323.1634)


   

7-BENZYLOXY-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

7-BENZYLOXY-4-HYDROXYQUINOLINE-3-CARBOXYLIC ACID ETHYL ESTER

C19H17NO4 (323.1158)


   

tert-Butyl 5-(benzyloxy)-1H-indole-1-carboxylate

tert-Butyl 5-(benzyloxy)-1H-indole-1-carboxylate

C20H21NO3 (323.1521)


   

1-(4-FLUOROPHENYL)-4-ISOPROPYL-2-PHENYL-1H-PYRROLE-3-CARBOXYLICACID

1-(4-FLUOROPHENYL)-4-ISOPROPYL-2-PHENYL-1H-PYRROLE-3-CARBOXYLICACID

C20H18FNO2 (323.1321)


   

tert-Butyl (2R)-N-(2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-hydroxyethyl)carbamate

tert-Butyl (2R)-N-(2-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)-2-hydroxyethyl)carbamate

C17H25NO5 (323.1733)


   

4-(4-methylphenyl)-2,2:6,2-terpyridine

4-(4-methylphenyl)-2,2:6,2-terpyridine

C22H17N3 (323.1422)


   

ethyl 2-oxo-2-(5-phenylmethoxy-1H-indol-3-yl)acetate

ethyl 2-oxo-2-(5-phenylmethoxy-1H-indol-3-yl)acetate

C19H17NO4 (323.1158)


   

Ethyl 1-benzyl-4-phenylpiperidine-4-carboxylate

Ethyl 1-benzyl-4-phenylpiperidine-4-carboxylate

C21H25NO2 (323.1885)


   

4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine

4-(2-Chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine

C16H23BClNO3 (323.1459)


   

1-(9H-fluoren-9-ylmethoxycarbonyl)azetidine-2-carboxylic acid

1-(9H-fluoren-9-ylmethoxycarbonyl)azetidine-2-carboxylic acid

C19H17NO4 (323.1158)


   

N-[cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide

N-[cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide

C14H21N5O2S (323.1416)


D - Dermatologicals > D11 - Other dermatological preparations > D11A - Other dermatological preparations > D11AH - Agents for dermatitis, excluding corticosteroids C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C172200 - JAK Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors

   

1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine

1-(2-Phenylethyl)-4-phenyl-4-acetoxypiperidine

C21H25NO2 (323.1885)


   

Remetinostat

Remetinostat

C16H21NO6 (323.1369)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C471 - Enzyme Inhibitor > C1946 - Histone Deacetylase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent

   

Benzamide, 4-amino-N-1-azabicyclo(3.3.1)non-4-yl-5-chloro-2-methoxy-

Benzamide, 4-amino-N-1-azabicyclo(3.3.1)non-4-yl-5-chloro-2-methoxy-

C16H22ClN3O2 (323.14)


   

2-Anilino-6-cyclohexylmethoxypurine

2-Anilino-6-cyclohexylmethoxypurine

C18H21N5O (323.1746)


   

1H-Imidazole-4-carboxamide, 1-((1R,2S)-2-hydroxy-1-(2-(1-naphthalenyl)ethyl)propyl)-

1H-Imidazole-4-carboxamide, 1-((1R,2S)-2-hydroxy-1-(2-(1-naphthalenyl)ethyl)propyl)-

C19H21N3O2 (323.1634)


   

Tolmicen

Tolmicen

C20H21NOS (323.1344)


D000890 - Anti-Infective Agents > D000935 - Antifungal Agents C254 - Anti-Infective Agent > C514 - Antifungal Agent

   

Risarestat

Risarestat

C16H21NO4S (323.1191)


C471 - Enzyme Inhibitor

   

Tolciclate

Tolciclate

C20H21NOS (323.1344)


D - Dermatologicals > D01 - Antifungals for dermatological use > D01A - Antifungals for topical use D000890 - Anti-Infective Agents > D000935 - Antifungal Agents

   

2-[2-[[2-Amino-4-[hydroxy(methyl)phosphoryl]butanoyl]amino]propanoylamino]propanoic acid

2-[2-[[2-Amino-4-[hydroxy(methyl)phosphoryl]butanoyl]amino]propanoylamino]propanoic acid

C11H22N3O6P (323.1246)


   

1-Amino-3-(4-methylphenyl)pyrido[1,2-a]benzimidazole-2,4-dicarbonitrile

1-Amino-3-(4-methylphenyl)pyrido[1,2-a]benzimidazole-2,4-dicarbonitrile

C20H13N5 (323.1171)


   

11-Hydroxynoracronycine

11-Hydroxynoracronycine

C19H17NO4 (323.1158)


   

(E)-N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-3-(4-fluorophenyl)prop-2-enamide

(E)-N-(5-amino-1-phenyl-1,2,4-triazol-3-yl)-3-(4-fluorophenyl)prop-2-enamide

C17H14FN5O (323.1182)


   

2-[(E)-2-(dimethylamino)ethenyl]-3-nitro-1-phenylindol-6-ol

2-[(E)-2-(dimethylamino)ethenyl]-3-nitro-1-phenylindol-6-ol

C18H17N3O3 (323.127)


   

Oxysonium

Oxysonium

C18H27O3S+ (323.1681)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent

   

H-Ala-ala-tyr-OH

H-Ala-ala-tyr-OH

C15H21N3O5 (323.1481)


   

(5-Hydroxy-2-phenyl-3-benzofuranyl)-(4-morpholinyl)methanone

(5-Hydroxy-2-phenyl-3-benzofuranyl)-(4-morpholinyl)methanone

C19H17NO4 (323.1158)


   

N-(1,3-benzodioxol-5-ylmethyl)-3,5-dimethyl-2-benzofurancarboxamide

N-(1,3-benzodioxol-5-ylmethyl)-3,5-dimethyl-2-benzofurancarboxamide

C19H17NO4 (323.1158)


   

[1-(5-Hydroxypentyl)indol-3-yl]-(4-hydroxyphenyl)methanone

[1-(5-Hydroxypentyl)indol-3-yl]-(4-hydroxyphenyl)methanone

C20H21NO3 (323.1521)


   

H-Pro-his-ala-OH

H-Pro-his-ala-OH

C14H21N5O4 (323.1593)


   

Deoxystreptamine-kanosaminide

Deoxystreptamine-kanosaminide

C12H25N3O7 (323.1692)


   

1,5-Naphthyridine-3-carboxamide, 6-ethoxy-1,4-dihydro-4-oxo-N-(phenylmethyl)-

1,5-Naphthyridine-3-carboxamide, 6-ethoxy-1,4-dihydro-4-oxo-N-(phenylmethyl)-

C18H17N3O3 (323.127)


   

5-(4-Chlorophenyl)-2,2-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentane-1,3-diol

5-(4-Chlorophenyl)-2,2-dimethyl-3-(1,2,4-triazol-1-ylmethyl)pentane-1,3-diol

C16H22ClN3O2 (323.14)


   

4-Piperidino-6-trifluoromethyl-2-(2-hydroxyphenyl)pyrimidine

4-Piperidino-6-trifluoromethyl-2-(2-hydroxyphenyl)pyrimidine

C16H16F3N3O (323.1245)


   

(6s)-2-Amino-6-(3-Methoxybiphenyl-3-Yl)-3,6-Dimethyl-5,6-Dihydropyrimidin-4(3h)-One

(6s)-2-Amino-6-(3-Methoxybiphenyl-3-Yl)-3,6-Dimethyl-5,6-Dihydropyrimidin-4(3h)-One

C19H21N3O2 (323.1634)


   

1-[(2r)-2-Aminobutanoyl]-N-(3-Chlorobenzyl)-L-Prolinamide

1-[(2r)-2-Aminobutanoyl]-N-(3-Chlorobenzyl)-L-Prolinamide

C16H22ClN3O2 (323.14)


   

Para-nitrobenzyl glutaryl glycinic acid

Para-nitrobenzyl glutaryl glycinic acid

C14H17N3O6 (323.1117)


   

Ritodrinium

Ritodrine hydrochloride

C17H22ClNO3 (323.1288)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013566 - Sympathomimetics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents Ritodrine (DU21220) hydrochloride is a potent and orally active β-adrenergic agonist. Ritodrine hydrochloride decreases preterm delivery and uterine contraction. Ritodrine hydrochloride has the potential for the research of preterm labor[1][2].

   

Renzaprida

Renzaprida

C16H22ClN3O2 (323.14)


D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists

   

AIDS-161807

7H-Pyrano(2,3-c)acridin-7-one, 3,12-dihydro-6,11-dihydroxy-3,3,12-trimethyl- (8CI)(9CI)

C19H17NO4 (323.1158)


   

2-[2-[(2-Amino-3-phenylpropanoyl)amino]propanoylamino]-3-hydroxypropanoic acid

2-[2-[(2-Amino-3-phenylpropanoyl)amino]propanoylamino]-3-hydroxypropanoic acid

C15H21N3O5 (323.1481)


   

10-Hydroxy-2,9-dimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-3-one

10-Hydroxy-2,9-dimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-3-one

C19H17NO4 (323.1158)


   

2-Hydroxy-9,10-dimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-3-one

2-Hydroxy-9,10-dimethoxy-5,6-dihydroisoquinolino[2,1-b]isoquinolin-3-one

C19H17NO4 (323.1158)


   

5-[(3-Aminopropyl)amino]-5-deoxyadenosine

5-[(3-Aminopropyl)amino]-5-deoxyadenosine

C13H21N7O3 (323.1706)


   

Akuammicine(1+)

Akuammicine(1+)

C20H23N2O2+ (323.1759)


An ammonium ion that is the conjugate acid of akuammicine, arising from the protonation of the tertiary amino group.

   

2-(8-hydroxy-2-oxotridecyl)-6-oxopyran-4-olate

2-(8-hydroxy-2-oxotridecyl)-6-oxopyran-4-olate

C18H27O5- (323.1858)


   

(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(2,4-diaminobutyl)oxolane-3,4-diol

(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(2,4-diaminobutyl)oxolane-3,4-diol

C13H21N7O3 (323.1706)


   

(2S,3R,4R)-2-azaniumyl-4-(carbamoyloxymethyl)-7-carboxy-3-hydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indol-5-olate

(2S,3R,4R)-2-azaniumyl-4-(carbamoyloxymethyl)-7-carboxy-3-hydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indol-5-olate

C14H17N3O6 (323.1117)


   

(2S,3R,4R)-2-amino-4-(carbamoyloxymethyl)-3,5-dihydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indole-7-carboxylic acid

(2S,3R,4R)-2-amino-4-(carbamoyloxymethyl)-3,5-dihydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indole-7-carboxylic acid

C14H17N3O6 (323.1117)


   

(2S,3R,4S)-2-azaniumyl-4-(carbamoyloxymethyl)-7-carboxy-3-hydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indol-5-olate

(2S,3R,4S)-2-azaniumyl-4-(carbamoyloxymethyl)-7-carboxy-3-hydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indol-5-olate

C14H17N3O6 (323.1117)


   

(2S,3R,4S)-2-amino-4-(carbamoyloxymethyl)-3,5-dihydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indole-7-carboxylic acid

(2S,3R,4S)-2-amino-4-(carbamoyloxymethyl)-3,5-dihydroxy-2,3,3a,4-tetrahydro-1H-pyrrolo[1,2-a]indole-7-carboxylic acid

C14H17N3O6 (323.1117)


   

(2E,4E,7R)-11-[(2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoate

(2E,4E,7R)-11-[(2R,3R)-3-(hydroxymethyl)-4-oxooxetan-2-yl]-3,5,7-trimethylundeca-2,4-dienoate

C18H27O5- (323.1858)


   

3-[3-(Benzenesulfonamido)-2-bicyclo[2.2.1]heptanyl]propanoic acid

3-[3-(Benzenesulfonamido)-2-bicyclo[2.2.1]heptanyl]propanoic acid

C16H21NO4S (323.1191)


   
   

2-[[3-(4H-imidazol-4-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]amino]acetic acid

2-[[3-(4H-imidazol-4-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]amino]acetic acid

C13H17N5O5 (323.123)


   

(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine

(2E,8E)-10-hydroxydeca-2,8-dien-4-ynoylcarnitine

C17H25NO5 (323.1733)


   

Propionyl adenylate

Propionyl adenylate

C13H17N5O5 (323.123)


   

2-(4-Ethoxyanilino)-3-methoxynaphthalene-1,4-dione

2-(4-Ethoxyanilino)-3-methoxynaphthalene-1,4-dione

C19H17NO4 (323.1158)


   

1-[3-[(8-methyl-5H-pyrimido[5,4-b]indol-4-yl)amino]propyl]-2-pyrrolidinone

1-[3-[(8-methyl-5H-pyrimido[5,4-b]indol-4-yl)amino]propyl]-2-pyrrolidinone

C18H21N5O (323.1746)


   

10-(4-methoxyphenyl)-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione

10-(4-methoxyphenyl)-3,4,5,6,7,9-hexahydro-2H-acridine-1,8-dione

C20H21NO3 (323.1521)


   

2-phenoxyacetic acid (8-methyl-2-oxo-1H-quinolin-3-yl)methyl ester

2-phenoxyacetic acid (8-methyl-2-oxo-1H-quinolin-3-yl)methyl ester

C19H17NO4 (323.1158)


   

1-[(1,2-Dimethyl-5-indolyl)methyl]-3-(phenylmethyl)thiourea

1-[(1,2-Dimethyl-5-indolyl)methyl]-3-(phenylmethyl)thiourea

C19H21N3S (323.1456)


   
   
   

N-(4-methoxyphenyl)-5-(phenoxymethyl)furan-2-carboxamide

N-(4-methoxyphenyl)-5-(phenoxymethyl)furan-2-carboxamide

C19H17NO4 (323.1158)


   

N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide

N-[4-[(cyclohexylamino)-oxomethyl]phenyl]-3-pyridinecarboxamide

C19H21N3O2 (323.1634)


   

N,N-diethyl-4-[oxo-(2,4,6-trimethylphenyl)methyl]benzamide

N,N-diethyl-4-[oxo-(2,4,6-trimethylphenyl)methyl]benzamide

C21H25NO2 (323.1885)


   

2-(3-amino-3-oxopropyl)-3-(4-methylbenzoyl)-2H-indazole 1-oxide

2-(3-amino-3-oxopropyl)-3-(4-methylbenzoyl)-2H-indazole 1-oxide

C18H17N3O3 (323.127)


   

1-ethyl-2-hydroxy-4-oxo-N-(pyridin-3-ylmethyl)quinoline-3-carboxamide

1-ethyl-2-hydroxy-4-oxo-N-(pyridin-3-ylmethyl)quinoline-3-carboxamide

C18H17N3O3 (323.127)


   

2-(2,3-dimethylphenoxy)-N-(2-oxo-1-benzopyran-6-yl)acetamide

2-(2,3-dimethylphenoxy)-N-(2-oxo-1-benzopyran-6-yl)acetamide

C19H17NO4 (323.1158)


   

8-(Diethylaminomethyl)-7-hydroxy-4-phenyl-1-benzopyran-2-one

8-(Diethylaminomethyl)-7-hydroxy-4-phenyl-1-benzopyran-2-one

C20H21NO3 (323.1521)


   

N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-methyl-4-pyridinecarboxamide

N-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]-N-methyl-4-pyridinecarboxamide

C18H17N3O3 (323.127)


   

1-Pyrrolidinyl-[5-(6-quinolinyloxymethyl)-3-isoxazolyl]methanone

1-Pyrrolidinyl-[5-(6-quinolinyloxymethyl)-3-isoxazolyl]methanone

C18H17N3O3 (323.127)


   

N-(2-hydroxyethyl)-3-methyl-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

N-(2-hydroxyethyl)-3-methyl-5H-indazolo[2,3-a][3,1]benzoxazine-9-carboxamide

C18H17N3O3 (323.127)


   

ML-236A carboxylate

ML-236A carboxylate

C18H27O5- (323.1858)


   

3-{[(E)-(2,4-dihydroxyphenyl)methylidene]amino}-2-propylquinazolin-4(3H)-one

3-{[(E)-(2,4-dihydroxyphenyl)methylidene]amino}-2-propylquinazolin-4(3H)-one

C18H17N3O3 (323.127)


   
   
   
   
   
   

1-(1,3-Benzodioxol-5-yl)-2-(1,2-dihydroimidazo[1,2-a]benzimidazol-4-yl)ethanol

1-(1,3-Benzodioxol-5-yl)-2-(1,2-dihydroimidazo[1,2-a]benzimidazol-4-yl)ethanol

C18H17N3O3 (323.127)


   

1-(Pyrrolidin-1-yl)propan-2-yl diphenylacetate

1-(Pyrrolidin-1-yl)propan-2-yl diphenylacetate

C21H25NO2 (323.1885)


   

2,2,7,7,9,9-hexamethyl-10-oxido-8H-pyrano[2,3-b]carbazol-10-ium

2,2,7,7,9,9-hexamethyl-10-oxido-8H-pyrano[2,3-b]carbazol-10-ium

C21H25NO2 (323.1885)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

6-Aminopenicilloyl-benzylamine

6-Aminopenicilloyl-benzylamine

C15H21N3O3S (323.1304)


   

beta-D-Tyvp-(1->3)-beta-D-GalpN-OMe

beta-D-Tyvp-(1->3)-beta-D-GalpN-OMe

C13H25NO8 (323.158)


   

5,5-dimethyl-2-[(5-methyl-4-phenyl-1H-pyrazol-3-yl)iminomethyl]cyclohexane-1,3-dione

5,5-dimethyl-2-[(5-methyl-4-phenyl-1H-pyrazol-3-yl)iminomethyl]cyclohexane-1,3-dione

C19H21N3O2 (323.1634)


   

(1S,12S,14R,15E)-15-ethylidene-17-methyl-3-aza-17-azoniapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraene-13-carboxylic acid

(1S,12S,14R,15E)-15-ethylidene-17-methyl-3-aza-17-azoniapentacyclo[12.3.1.02,10.04,9.012,17]octadeca-2(10),4,6,8-tetraene-13-carboxylic acid

C20H23N2O2+ (323.1759)


   

2-Phenylamino-4,6-diphenylpyrimidine

2-Phenylamino-4,6-diphenylpyrimidine

C22H17N3 (323.1422)


   
   
   

Octanal O-[(pentafluorophenyl)methyl]oxime

Octanal O-[(pentafluorophenyl)methyl]oxime

C15H18F5NO (323.1308)


   

5-(Diethoxymethyl)-3-[(diethoxyphosphinyl)methyl]-2-isoxazoline

5-(Diethoxymethyl)-3-[(diethoxyphosphinyl)methyl]-2-isoxazoline

C13H26NO6P (323.1498)


   

2-Deamino-2-hydroxyneamine

2-Deamino-2-hydroxyneamine

C12H25N3O7 (323.1692)


An amino cyclitol glycoside that is 2-deoxystreptamine in which the pro-R hydroxy group is substituted by a 6-amino-6-deoxy-alpha-D-glucosyl residue.

   

methyl 2,2-dimethyl-4,6-dioxo-5-[(E)-N-prop-2-enoxy-C-propylcarbonimidoyl]cyclohexane-1-carboxylate

methyl 2,2-dimethyl-4,6-dioxo-5-[(E)-N-prop-2-enoxy-C-propylcarbonimidoyl]cyclohexane-1-carboxylate

C17H25NO5 (323.1733)


   

3-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methoxyquinoline

3-[2-(3,4-Dimethoxyphenyl)ethyl]-4-methoxyquinoline

C20H21NO3 (323.1521)


   

Rutacridone epoxide

Rutacridone epoxide

C19H17NO4 (323.1158)


   

N-Methoxycarbonylanonaine

N-Methoxycarbonylanonaine

C19H17NO4 (323.1158)


   

(S)-Neolitsine

(S)-Neolitsine

C19H17NO4 (323.1158)


   

cyclo-L-2-tert-DMA-Trp-L-Ala Delta(10,11)

cyclo-L-2-tert-DMA-Trp-L-Ala Delta(10,11)

C19H21N3O2 (323.1634)


   

(S)-stylopine

(S)-stylopine

C19H17NO4 (323.1158)


A berberine alkaloid isolated from the plants of the family papaveraceae.

   
   
   
   
   
   

(S)-Renzapride

(S)-Renzapride

C16H22ClN3O2 (323.14)


(S)-Renzapride ((S)-BRL 24924) is the isomer of HY-14147 Renzapride. Renzapride is a 5-HT4 receptor agonist with a Ki value of 115 nM. Renzapride also is a 5HT2b and 5HT3 receptor antagonist. Renzapride can be used for constipation predominant irritable bowel syndrome (C-IBS) study[1][2].

   

Cbz-Asn-Gly-OH

Cbz-Asn-Gly-OH

C14H17N3O6 (323.1117)


Cbz-Asn-Gly-OH is a polypeptide that can be found by peptide screening. Peptide screening is a research tool that pools active peptides primarily by immunoassay. Peptide screening can be used for protein interaction, functional analysis, epitope screening, especially in the field of agent research and development[1].

   

(1s,12s)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene

(1s,12s)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene

C19H17NO4 (323.1158)


   

15-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaen-16-ol

15-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaen-16-ol

C19H17NO4 (323.1158)


   

(3r)-3-(4-methoxy-5-methyl-6-oxopyran-2-yl)butyl (2r)-5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboxylate

(3r)-3-(4-methoxy-5-methyl-6-oxopyran-2-yl)butyl (2r)-5-hydroxy-3,4-dihydro-2h-pyrrole-2-carboxylate

C16H21NO6 (323.1369)


   

1-{5-hydroxy-2,8,8-trimethyl-9h,10h,11h-phenanthro[3,4-d][1,3]oxazol-4-yl}ethanone

1-{5-hydroxy-2,8,8-trimethyl-9h,10h,11h-phenanthro[3,4-d][1,3]oxazol-4-yl}ethanone

C20H21NO3 (323.1521)


   

(3s,6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

(3s,6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

C19H21N3O2 (323.1634)


   

7-hydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

7-hydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C17H25NO5 (323.1733)


   

2-{[(4-butanoyl-3-methoxy-5-methylphenyl)(hydroxy)methylidene]amino}-3-hydroxypropanoic acid

2-{[(4-butanoyl-3-methoxy-5-methylphenyl)(hydroxy)methylidene]amino}-3-hydroxypropanoic acid

C16H21NO6 (323.1369)


   

5-hydroxy-6-methyl-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one

5-hydroxy-6-methyl-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1,6-dihydropyrazin-2-one

C19H21N3O2 (323.1634)


   

11-hydroxy-3,10-dimethoxy-7,8-dihydro-6-azatetraphen-2-one

11-hydroxy-3,10-dimethoxy-7,8-dihydro-6-azatetraphen-2-one

C19H17NO4 (323.1158)


   

(6z)-5-hydroxy-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1h-pyrazine-2,3-dione

(6z)-5-hydroxy-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-1h-pyrazine-2,3-dione

C18H17N3O3 (323.127)


   

6,7-dimethoxy-1-(4-methoxybenzoyl)isoquinoline

6,7-dimethoxy-1-(4-methoxybenzoyl)isoquinoline

C19H17NO4 (323.1158)


   

2-(hydroxymethyl)-6-[3-(methoxymethyl)indol-1-yl]oxane-3,4,5-triol

2-(hydroxymethyl)-6-[3-(methoxymethyl)indol-1-yl]oxane-3,4,5-triol

C16H21NO6 (323.1369)


   

5,10-dihydroxy-2,2,11-trimethyl-1-oxa-11-azatetracen-6-one

5,10-dihydroxy-2,2,11-trimethyl-1-oxa-11-azatetracen-6-one

C19H17NO4 (323.1158)


   

(r)-stylopine

(r)-stylopine

C19H17NO4 (323.1158)


   

5-methyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-5-yl acetate

5-methyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-5-yl acetate

C16H21NO6 (323.1369)


   

(2-{9-methoxy-2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)dimethylamine

(2-{9-methoxy-2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)dimethylamine

C20H21NO3 (323.1521)


   

(2s)-2-[(4-aminophenyl)formamido]-3-(1h-indol-3-yl)propanoic acid

(2s)-2-[(4-aminophenyl)formamido]-3-(1h-indol-3-yl)propanoic acid

C18H17N3O3 (323.127)


   

n-[1-(4,5-dihydroxy-6-methyloxan-2-yl)-2-hydroxypyrimidin-4-ylidene]-3-methylbut-2-enamide

n-[1-(4,5-dihydroxy-6-methyloxan-2-yl)-2-hydroxypyrimidin-4-ylidene]-3-methylbut-2-enamide

C15H21N3O5 (323.1481)


   

n-[4-(benzoyloxy)butyl]-3-phenylprop-2-enimidic acid

n-[4-(benzoyloxy)butyl]-3-phenylprop-2-enimidic acid

C20H21NO3 (323.1521)


   

5-hydroxy-6-{[2-(2-methylbut-3-en-2-yl)indol-3-ylidene]methyl}-1,4-dihydropyrazine-2,3-dione

5-hydroxy-6-{[2-(2-methylbut-3-en-2-yl)indol-3-ylidene]methyl}-1,4-dihydropyrazine-2,3-dione

C18H17N3O3 (323.127)


   

(2r)-5-hydroxy-11-methyl-2-[(2s)-2-methyloxiran-2-yl]-1h,2h-furo[2,3-c]acridin-6-one

(2r)-5-hydroxy-11-methyl-2-[(2s)-2-methyloxiran-2-yl]-1h,2h-furo[2,3-c]acridin-6-one

C19H17NO4 (323.1158)


   

5-hydroxy-2-(2-hydroxypropan-2-yl)-11-methylfuro[2,3-c]acridin-6-one

5-hydroxy-2-(2-hydroxypropan-2-yl)-11-methylfuro[2,3-c]acridin-6-one

C19H17NO4 (323.1158)


   

(1r,12r)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene

(1r,12r)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene

C19H17NO4 (323.1158)


   

(2s,3r,4s,5s,6r)-2-[(3-ethyl-1h-indol-4-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

(2s,3r,4s,5s,6r)-2-[(3-ethyl-1h-indol-4-yl)oxy]-6-(hydroxymethyl)oxane-3,4,5-triol

C16H21NO6 (323.1369)


   

2-[(4-aminophenyl)formamido]-3-(1h-indol-3-yl)propanoic acid

2-[(4-aminophenyl)formamido]-3-(1h-indol-3-yl)propanoic acid

C18H17N3O3 (323.127)


   

(1s,12r)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene

(1s,12r)-23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene

C19H17NO4 (323.1158)


   

16-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaen-17-ol

16-methoxy-11-methyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,12,14(19),15,17-heptaen-17-ol

C19H17NO4 (323.1158)


   

4-({2-imino-4-[(4-methoxyphenyl)methyl]-3-methylimidazol-1-yl}methyl)phenol

4-({2-imino-4-[(4-methoxyphenyl)methyl]-3-methylimidazol-1-yl}methyl)phenol

C19H21N3O2 (323.1634)


   

11-hydroxy-3,4-dimethoxy-7,8-dihydro-6-azatetraphen-10-one

11-hydroxy-3,4-dimethoxy-7,8-dihydro-6-azatetraphen-10-one

C19H17NO4 (323.1158)


   

8,10-dimethoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

8,10-dimethoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

C20H21NO3 (323.1521)


   

2-methyl-1-(6-methylheptyl)-9h-carbazole-3,4-dione

2-methyl-1-(6-methylheptyl)-9h-carbazole-3,4-dione

C21H25NO2 (323.1885)


   

1-[(9s)-16-hydroxy-15-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-10-yl]propan-1-one

1-[(9s)-16-hydroxy-15-methoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2,4,6,13,15-hexaen-10-yl]propan-1-one

C20H21NO3 (323.1521)


   

8,11-dihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

8,11-dihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

C19H17NO4 (323.1158)


   

2-methyl-1-(5-methylheptyl)-9h-carbazole-3,4-dione

2-methyl-1-(5-methylheptyl)-9h-carbazole-3,4-dione

C21H25NO2 (323.1885)


   

1-[(12r)-16-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]ethanone

1-[(12r)-16-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl]ethanone

C19H17NO4 (323.1158)


   

7,11-dihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

7,11-dihydroxy-2,2,5-trimethyl-1-oxa-5-azatetraphen-10-one

C19H17NO4 (323.1158)


   

4-methoxy-3-methyl-6-[9-(1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]pyran-2-one

4-methoxy-3-methyl-6-[9-(1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]pyran-2-one

C20H21NO3 (323.1521)


   

1-{16-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl}ethanone

1-{16-hydroxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaen-11-yl}ethanone

C19H17NO4 (323.1158)


   

3-hydroxy-4,11-dimethoxy-7,8-dihydro-6-azatetraphen-10-one

3-hydroxy-4,11-dimethoxy-7,8-dihydro-6-azatetraphen-10-one

C19H17NO4 (323.1158)


   

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-4-methylpentanamide

n-[2-hydroxy-1-(5-hydroxy-6-methyloxan-2-yl)pyrimidin-4-ylidene]-4-methylpentanamide

C16H25N3O4 (323.1845)


   

6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}piperazine-2,3,5-trione

6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}piperazine-2,3,5-trione

C18H17N3O3 (323.127)


   

(1s,4s,4ar,7r)-7-hydroxy-1-isopropyl-4-isothiocyanato-4,7-dimethyl-3,4a,5,6-tetrahydro-2h-naphthalene-1-carboxylic acid

(1s,4s,4ar,7r)-7-hydroxy-1-isopropyl-4-isothiocyanato-4,7-dimethyl-3,4a,5,6-tetrahydro-2h-naphthalene-1-carboxylic acid

C17H25NO3S (323.1555)


   

(1r,5s,16s)-5-methyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-5-yl acetate

(1r,5s,16s)-5-methyl-3,7-dioxo-2,8-dioxa-13-azatricyclo[8.5.1.0¹³,¹⁶]hexadec-10-en-5-yl acetate

C16H21NO6 (323.1369)


   

(2s,6r)-2-methoxy-3,4,6-trimethyl-9-phenyl-7-oxa-11-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),3,8,10-tetraen-12-ol

(2s,6r)-2-methoxy-3,4,6-trimethyl-9-phenyl-7-oxa-11-azatricyclo[6.4.0.0²,⁶]dodeca-1(12),3,8,10-tetraen-12-ol

C20H21NO3 (323.1521)


   

(3s)-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methylidene-3h-pyrazine-2,5-diol

(3s)-3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methylidene-3h-pyrazine-2,5-diol

C19H21N3O2 (323.1634)


   

7-methoxy-4-(5-phenylpentyl)-1h-indole-2,3-dione

7-methoxy-4-(5-phenylpentyl)-1h-indole-2,3-dione

C20H21NO3 (323.1521)


   

4-[(6e,8z)-2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(6e,8z)-2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C17H25NO5 (323.1733)


   

4-(2,9-dihydroxy-5,7-dimethyl-4-oxodeca-5,7-dien-1-yl)-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-(2,9-dihydroxy-5,7-dimethyl-4-oxodeca-5,7-dien-1-yl)-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C17H25NO5 (323.1733)


   

1-[(9s)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl]ethanone

1-[(9s)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl]ethanone

C20H21NO3 (323.1521)


   

(2s)-1-[(3-acetyl-2-hydroxy-4,6-dimethoxyphenyl)methyl]pyrrolidine-2-carboxylic acid

(2s)-1-[(3-acetyl-2-hydroxy-4,6-dimethoxyphenyl)methyl]pyrrolidine-2-carboxylic acid

C16H21NO6 (323.1369)


   

1-(3,3-dimethyloxiran-2-yl)-5-methoxy-1h,6h-furo[3,4-c]carbazol-3-one

1-(3,3-dimethyloxiran-2-yl)-5-methoxy-1h,6h-furo[3,4-c]carbazol-3-one

C19H17NO4 (323.1158)


   

(2s)-2-{[(4-butanoyl-3-methoxy-5-methylphenyl)(hydroxy)methylidene]amino}-3-hydroxypropanoic acid

(2s)-2-{[(4-butanoyl-3-methoxy-5-methylphenyl)(hydroxy)methylidene]amino}-3-hydroxypropanoic acid

C16H21NO6 (323.1369)


   

(2-{10-methoxy-2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)dimethylamine

(2-{10-methoxy-2h-phenanthro[3,4-d][1,3]dioxol-5-yl}ethyl)dimethylamine

C20H21NO3 (323.1521)


   

(2r,3r,4r)-2,3,4,5-tetrahydroxypentyl (2s)-2-(1h-indol-3-yl)propanoate

(2r,3r,4r)-2,3,4,5-tetrahydroxypentyl (2s)-2-(1h-indol-3-yl)propanoate

C16H21NO6 (323.1369)


   

3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methylidene-3h-pyrazine-2,5-diol

3-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methyl}-6-methylidene-3h-pyrazine-2,5-diol

C19H21N3O2 (323.1634)


   

(2e)-n-{4-[(e)-benzoyloxy]butyl}-3-phenylprop-2-enimidic acid

(2e)-n-{4-[(e)-benzoyloxy]butyl}-3-phenylprop-2-enimidic acid

C20H21NO3 (323.1521)


   

8,9-dimethoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

8,9-dimethoxy-3,3,5-trimethyl-11h-pyrano[3,2-a]carbazole

C20H21NO3 (323.1521)


   

methyl (4ar,7ar)-7-(hydroxymethyl)-2-(4-methoxy-4-oxobutyl)-1-oxo-4ah,5h,7ah-cyclopenta[c]pyridine-4-carboxylate

methyl (4ar,7ar)-7-(hydroxymethyl)-2-(4-methoxy-4-oxobutyl)-1-oxo-4ah,5h,7ah-cyclopenta[c]pyridine-4-carboxylate

C16H21NO6 (323.1369)


   

(3r,6e)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

(3r,6e)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

C19H21N3O2 (323.1634)


   

6,7,8,13-tetramethoxy-2-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-1,3,5,7,9(16),10,12,14-octaene

6,7,8,13-tetramethoxy-2-azatetracyclo[7.6.1.0⁵,¹⁶.0¹⁰,¹⁵]hexadeca-1,3,5,7,9(16),10,12,14-octaene

C19H17NO4 (323.1158)


   

methyl 7-(hydroxymethyl)-2-(4-methoxy-4-oxobutyl)-1-oxo-4ah,5h,7ah-cyclopenta[c]pyridine-4-carboxylate

methyl 7-(hydroxymethyl)-2-(4-methoxy-4-oxobutyl)-1-oxo-4ah,5h,7ah-cyclopenta[c]pyridine-4-carboxylate

C16H21NO6 (323.1369)


   

3,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene

3,15,16-trimethoxy-10-methyl-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,13,15-heptaene

C20H21NO3 (323.1521)


   

(2r)-5-hydroxy-11-methyl-2-[(2r)-2-methyloxiran-2-yl]-1h,2h-furo[2,3-c]acridin-6-one

(2r)-5-hydroxy-11-methyl-2-[(2r)-2-methyloxiran-2-yl]-1h,2h-furo[2,3-c]acridin-6-one

C19H17NO4 (323.1158)


   

methyl (12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene-11-carboxylate

methyl (12r)-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,14,16,18-hexaene-11-carboxylate

C19H17NO4 (323.1158)


   

1-[(9r)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl]ethanone

1-[(9r)-15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl]ethanone

C20H21NO3 (323.1521)


   

(1r)-1-[(2s)-3,3-dimethyloxiran-2-yl]-5-methoxy-1h,6h-furo[3,4-c]carbazol-3-one

(1r)-1-[(2s)-3,3-dimethyloxiran-2-yl]-5-methoxy-1h,6h-furo[3,4-c]carbazol-3-one

C19H17NO4 (323.1158)


   

methyl 1-methoxy-4-(3-methylbut-2-en-1-yl)-9h-carbazole-3-carboxylate

methyl 1-methoxy-4-(3-methylbut-2-en-1-yl)-9h-carbazole-3-carboxylate

C20H21NO3 (323.1521)


   

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-4-methylpentanamide

n-{2-hydroxy-1-[(2r,5s,6r)-5-hydroxy-6-methyloxan-2-yl]pyrimidin-4-ylidene}-4-methylpentanamide

C16H25N3O4 (323.1845)


   

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15(23),16(20),21-hexaene

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-2,4(8),9,15(23),16(20),21-hexaene

C19H17NO4 (323.1158)


   

4-methoxy-3-methyl-6-[(2e,4e,6e,8e)-9-(1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]pyran-2-one

4-methoxy-3-methyl-6-[(2e,4e,6e,8e)-9-(1h-pyrrol-2-yl)nona-2,4,6,8-tetraen-2-yl]pyran-2-one

C20H21NO3 (323.1521)


   

23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene

23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.10.1.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene

C19H17NO4 (323.1158)


   

4-({2-imino-5-[(4-methoxyphenyl)methyl]-3-methyl-1h-imidazol-4-yl}methyl)phenol

4-({2-imino-5-[(4-methoxyphenyl)methyl]-3-methyl-1h-imidazol-4-yl}methyl)phenol

C19H21N3O2 (323.1634)


   

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-[hydroxy(methyl)phosphoryl]butylidene]amino}-1-hydroxypropylidene]amino}propanoic acid

(2s)-2-{[(2s)-2-{[(2s)-2-amino-1-hydroxy-4-[hydroxy(methyl)phosphoryl]butylidene]amino}-1-hydroxypropylidene]amino}propanoic acid

C11H22N3O6P (323.1246)


   

(1s,4s,5r,6s,7r,17s)-7-hydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

(1s,4s,5r,6s,7r,17s)-7-hydroxy-4,5,6-trimethyl-2,9-dioxa-14-azatricyclo[9.5.1.0¹⁴,¹⁷]heptadec-11-ene-3,8-dione

C17H25NO5 (323.1733)


   

(12r)-17-methoxy-11,18-dimethyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

(12r)-17-methoxy-11,18-dimethyl-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8(20),14,16,18-hexaene

C20H21NO3 (323.1521)


   

n-{1-[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]-2-hydroxypyrimidin-4-ylidene}-3-methylbut-2-enamide

n-{1-[(2r,4r,5s,6r)-4,5-dihydroxy-6-methyloxan-2-yl]-2-hydroxypyrimidin-4-ylidene}-3-methylbut-2-enamide

C15H21N3O5 (323.1481)


   

1-{15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl}ethanone

1-{15,16-dimethoxy-10-azatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(16),2,4,6,13(17),14-hexaen-10-yl}ethanone

C20H21NO3 (323.1521)


   

1-hydroxy-3-methoxy-10-methyl-4-(3-methylbut-2-en-1-yl)acridin-9-one

1-hydroxy-3-methoxy-10-methyl-4-(3-methylbut-2-en-1-yl)acridin-9-one

C20H21NO3 (323.1521)


   

4-[(2r,5r,6e,8e)-2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(2r,5r,6e,8e)-2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C17H25NO5 (323.1733)


   

4-[(2r,5e,7e)-2,9-dihydroxy-5,7-dimethyl-4-oxodeca-5,7-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-[(2r,5e,7e)-2,9-dihydroxy-5,7-dimethyl-4-oxodeca-5,7-dien-1-yl]-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C17H25NO5 (323.1733)


   

4-(2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl)-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

4-(2,5-dihydroxy-5,7-dimethyl-4-oxodeca-6,8-dien-1-yl)-6-hydroxy-4,5-dihydro-3h-pyridin-2-one

C17H25NO5 (323.1733)


   

1-hydroxy-3-methoxy-10-methyl-2-(3-methylbut-2-en-1-yl)acridin-9-one

1-hydroxy-3-methoxy-10-methyl-2-(3-methylbut-2-en-1-yl)acridin-9-one

C20H21NO3 (323.1521)


   

2-[(2-hydroxy-3,4-dihydroquinolin-8-yl)oxy]-5-methoxy-6-methyloxane-3,4-diol

2-[(2-hydroxy-3,4-dihydroquinolin-8-yl)oxy]-5-methoxy-6-methyloxane-3,4-diol

C16H21NO6 (323.1369)


   

(3r,6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

(3r,6z)-3-methyl-6-{[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]methylidene}-3h-pyrazine-2,5-diol

C19H21N3O2 (323.1634)


   

4,5-bis[(4-methoxyphenyl)methyl]-1,3-dihydroimidazol-2-imine

4,5-bis[(4-methoxyphenyl)methyl]-1,3-dihydroimidazol-2-imine

C19H21N3O2 (323.1634)


   

2-methyl-1-[(5s)-5-methylheptyl]-9h-carbazole-3,4-dione

2-methyl-1-[(5s)-5-methylheptyl]-9h-carbazole-3,4-dione

C21H25NO2 (323.1885)


   

23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene

23-methyl-5,7,16,18-tetraoxa-23-azahexacyclo[10.9.2.0²,¹⁰.0⁴,⁸.0¹³,²¹.0¹⁵,¹⁹]tricosa-2,4(8),9,13,15(19),20-hexaene

C19H17NO4 (323.1158)


   

(2r)-5-hydroxy-2-(3-hydroxyprop-1-en-2-yl)-11-methyl-1h,2h-furo[2,3-c]acridin-6-one

(2r)-5-hydroxy-2-(3-hydroxyprop-1-en-2-yl)-11-methyl-1h,2h-furo[2,3-c]acridin-6-one

C19H17NO4 (323.1158)


   

2,3,4,5-tetrahydroxypentyl 2-(1h-indol-3-yl)propanoate

2,3,4,5-tetrahydroxypentyl 2-(1h-indol-3-yl)propanoate

C16H21NO6 (323.1369)